Cwm, LLC Novo Cure LTD Transaction History

Cwm, LLC

$28.4 Billion
Q2 2025

A detailed history of Cwm, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Cwm, LLC holds 2,666 shares of NVCR stock, worth $39,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,666

Previous 2,511 6.17%

Holding current value

$39,083

Previous $45,000 4.44%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 25, 2025	BUY	$15.37 - $19.4 $2,382 - $3,007	155 Added 6.17%	2,666 $47,000
Q1 2025 May 01, 2025	BUY	$17.82 - $30.19 $712 - $1,207	40 Added 1.62%	2,511 $45,000
Q4 2024 Feb 04, 2025	BUY	$14.54 - $33.41 $4,580 - $10,524	315 Added 14.61%	2,471 $74,000
Q3 2024 Oct 08, 2024	SELL	$15.61 - $23.34 $48,781 - $72,937	-3,125 Reduced 59.17%	2,156 $34,000
Q2 2024 Jul 09, 2024	BUY	$11.83 - $24.05 $40,340 - $82,010	3,410 Added 182.26%	5,281 $90,000
Q1 2024 Apr 05, 2024	BUY	$12.42 - $17.29 $1,440 - $2,005	116 Added 6.61%	1,871 $29,000
Q4 2023 Feb 01, 2024	SELL	$11.13 - $15.78 $23,773 - $33,706	-2,136 Reduced 54.9%	1,755 $26,000
Q3 2023 Oct 11, 2023	BUY	$16.15 - $42.35 $35,271 - $92,492	2,184 Added 127.94%	3,891 $63,000
Q2 2023 Aug 03, 2023	SELL	$40.29 - $82.51 $13,859 - $28,383	-344 Reduced 16.77%	1,707 $71,000
Q1 2023 Apr 28, 2023	SELL	$56.44 - $118.81 $1,580 - $3,326	-28 Reduced 1.35%	2,051 $123,000
Q4 2022 Feb 01, 2023	BUY	$63.98 - $85.37 $15,227 - $20,318	238 Added 12.93%	2,079 $152,000
Q3 2022 Oct 27, 2022	BUY	$67.99 - $89.57 $6,255 - $8,240	92 Added 5.26%	1,841 $140,000
Q2 2022 Jul 28, 2022	BUY	$56.6 - $89.9 $7,527 - $11,956	133 Added 8.23%	1,749 $122,000
Q1 2022 Apr 21, 2022	BUY	$60.15 - $84.52 $22,917 - $32,202	381 Added 30.85%	1,616 $134,000
Q4 2021 Jan 31, 2022	SELL	$75.08 - $121.99 $10,961 - $17,810	-146 Reduced 10.57%	1,235 $93,000
Q1 2021 Sep 15, 2021	BUY	$124.11 - $190.17 $2,109 - $3,232	17 Added 1.25%	1,381 $306,000
Q1 2021 Apr 27, 2021	SELL	$124.11 - $190.17 $2,109 - $3,232	-17 Reduced 1.23%	1,364 $180,000
Q4 2020 Sep 15, 2021	BUY	$112.16 - $174.14 $8,412 - $13,060	75 Added 5.74%	1,381 $306,000
Q4 2020 Jan 27, 2021	SELL	$112.16 - $174.14 $8,412 - $13,060	-75 Reduced 5.43%	1,306 $226,000
Q3 2020 Sep 15, 2021	BUY	$58.05 - $111.31 $7,256 - $13,913	125 Added 9.95%	1,381 $306,000
Q3 2020 Oct 19, 2020	SELL	$58.05 - $111.31 $7,256 - $13,913	-125 Reduced 9.05%	1,256 $140,000
Q2 2020 Sep 15, 2021	SELL	$57.2 - $74.41 $138,824 - $180,593	-2,427 Reduced 63.73%	1,381 $306,000
Q2 2020 Jul 22, 2020	BUY	$57.2 - $74.41 $138,824 - $180,593	2,427 Added 175.74%	3,808 $226,000
Q1 2020 Sep 15, 2021	SELL	$57.05 - $95.75 $138,460 - $232,385	-2,427 Reduced 63.73%	1,381 $306,000
Q1 2020 Apr 28, 2020	BUY	$57.05 - $95.75 $138,460 - $232,385	2,427 Added 175.74%	3,808 $256,000
Q4 2019 Sep 14, 2021	SELL	$68.3 - $93.8 $165,764 - $227,652	-2,427 Reduced 63.73%	1,381 $306,000
Q4 2019 Jan 27, 2020	BUY	$68.3 - $93.8 $165,764 - $227,652	2,427 Added 175.74%	3,808 $321,000
Q3 2019 Sep 14, 2021	BUY	$61.86 - $97.8 $83,820 - $132,519	1,355 Added 5211.54%	1,381 $306,000
Q3 2019 Oct 22, 2019	SELL	$61.86 - $97.8 $83,820 - $132,519	-1,355 Reduced 98.12%	26 $2,000
Q2 2019 Sep 14, 2021	BUY	$42.22 - $63.23 $58,305 - $87,320	1,381 New	1,381 $306,000
Q2 2019 Jul 31, 2019	SELL	$42.22 - $63.23 $58,305 - $87,320	-1,381 Closed	0 $0
Q1 2019 Sep 02, 2021	SELL	$31.96 - $56.12 $122,055 - $214,322	-3,819 Reduced 73.44%	1,381 $0
Q2 2018 Jul 31, 2018	BUY	$19.85 - $32.0 $103,220 - $166,400	5,200 New	5,200 $163,000

Others Institutions Holding NVCR

# of Institutions

285

Shares Held

77.5M

Call Options Held

943K

Put Options Held

155K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.54B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account